These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22146029)

  • 21. National HIV treatment guidelines in Tanzania and Ethiopia: are they legitimate rationing tools?
    Johansson KA; Jerene D; Norheim OF
    J Med Ethics; 2008 Jun; 34(6):478-83. PubMed ID: 18511624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Priority setting and the ethics of resource allocation within VA healthcare facilities: results of a survey.
    Foglia MB; Pearlman RA; Bottrell MM; Altemose JA; Fox E
    Organ Ethic; 2008; 4(2):83-96. PubMed ID: 18839751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
    Torres MA
    Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?
    Abdool Karim Q; Bayer R
    Dev World Bioeth; 2013 Aug; 13(2):ii-iii. PubMed ID: 23865982
    [No Abstract]   [Full Text] [Related]  

  • 25. Costs associated with combination antiretroviral therapy in HIV-infected patients.
    Yazdanpanah Y
    J Antimicrob Chemother; 2004 Apr; 53(4):558-61. PubMed ID: 14985277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equity, health, care and values: an economist's perspective.
    Zamagni S
    Dolentium Hominum; 1995; 10(1):203-9. PubMed ID: 15839021
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimizing HIV treatment programs.
    Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
    Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights?
    Golan O; Hansen P; Kaplan G; Tal O
    Health Policy; 2011 Oct; 102(2-3):126-35. PubMed ID: 21071107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Providing antiretroviral therapy for HIV infection.
    Steinbrook R
    N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for Action on HIV Treatment and Care Systems in low and middle-income countries: background and introduction.
    Ross DA; South A; Weller I; Hakim J
    AIDS; 2012 Dec; 26 Suppl 2():S93-5. PubMed ID: 23303437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What reasons do those with practical experience use in deciding on priorities for healthcare resources? A qualitative study.
    Hasman A; McIntosh E; Hope T
    J Med Ethics; 2008 Sep; 34(9):658-63. PubMed ID: 18757635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-of-life decisions as bedside rationing. An ethical analysis of life support restrictions in an Indian neonatal unit.
    Miljeteig I; Johansson KA; Sayeed SA; Norheim OF
    J Med Ethics; 2010 Aug; 36(8):473-8. PubMed ID: 20663764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inequalities in the distribution of rural primary care physicians in two remote neighboring prefectures of Greece and Albania.
    Theodorakis PN; Mantzavinis GD
    Rural Remote Health; 2005; 5(3):457. PubMed ID: 16134954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Priority to the young or to those with least lifetime health?
    Norheim OF
    Am J Bioeth; 2010 Apr; 10(4):60-1. PubMed ID: 20379928
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rationalization, rationing, prioritization: terminology and ethical approaches to the allocation of limited resources in hematology/oncology].
    Winkler E
    Onkologie; 2011; 34 Suppl 1():2-5. PubMed ID: 21389761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
    Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
    Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
    [No Abstract]   [Full Text] [Related]  

  • 37. Who is entitled to what?
    Lamm RD
    Healthc Financ Manage; 2003 Sep; 57(9):74-7. PubMed ID: 14503147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.